BioSpace News Archive

Precision Guard 360, one of the largest and most trusted disinfectant service providers in South Florida, has expanded its offering to include a revolutionary, FDA-approved solution for long-term protection of workplaces, hotels and restaurants from harmful germs.

Vidence, LLC, an oncology informatics company, was officially launched today as an independent entity to provide the world’s leading cancer researchers, innovators and providers with the most comprehensive clinical and genomic data and insights

Aesculap Implant Systems, LLC today announced that it has been five years since the organization received FDA approval to market the activL® Artificial Disc in the United States.

Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced that, further to its press releases of January 17, 2019 and December 4, 2019, its proposal entitled “DispersinB® the missing link in wound care – Clinical evaluation of DispersinB®

Mylan N.V. (NASDAQ: MYL) today announced that the U.S. District Court for the Northern District of West Virginia invalidated Biogen’s Tecfidera® patent, U.S. Patent No. 8,399,514, for lack of written description.

– Application of ImmTOR plus Sarepta’s investigational gene therapies will be evaluated for Duchenne Muscular Dystrophy and Limb-Girdle Muscular Dystrophies – CAMBRIDGE, Mass. and WATERTOWN, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Sarepta Therapeutics (NASDAQ: SRPT), the leader in precision genetic medicine for rare diseases, and Selecta Biosciences, Inc. (NASDAQ: SELB) today announced that they have entered into a Research License and Option agreement granting Sarepta an option to lice

As states lift some restrictions designed to protect public health against furthering the spread of COVID-19, people across the country are wondering how to safely engage in activities this summer such as gathering with friends, traveling and going to the beach.

Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announced that David Fischel, Chairman and CEO, will present at the Cowen 5th Annual FutureHealth Conference on Thursday, June 25, 2020 at 10:15 am EDT.

The Lausanne University Hospital and IntraOp Medical Corporation have announced a research and development collaboration to accelerate the development of FLASH radiotherapy toward first human trials.

New Bayer herbicide provides excellent control of wild oat, plus other grass and broadleaf weeds in durum, spring and winter wheat